focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.00
Bid: 1,753.00
Ask: 1,754.00
Change: -19.00 (-1.07%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,740.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 03rd Apr 2014 09:05

Associated British Foods: Citi increases target price from 2350p to 3000p, while its neutral rating remains unchanged.Booker Group: Investec shifts target price from 172p to 178p retaining a buy recommendation.BSkyB: HSBC Holdings moves target price from 600p to 610p, while keeping its underweight rating.Burberry: Deutsche Bank cuts target price from 1600p to 1575p maintaining its hold recommendation.CSR: N+1 Singer raises target price to 777p and reiterates its hold recommendation.Daily Mail & General Trust: Jefferies increases target price from 800p to 1016p and maintains a buy recommendation.Direct Line Group: Berenberg ups target price from 230p to 254p and keeps a hold recommendation.easyJet: JP Morgan raises target price from 1725p to 1965p and reiterates an overweight rating.First Group: JP Morgan lowers target price from 165p to 156p and keeps an overweight rating.Glaxo Smith Kline: JP Morgan reduces target price from 1750p to 1700p leaving its neutral rating unchanged.Greene King: JP Morgan lowers target price from 960p to 940p maintaining a neutral rating.Heritage Oil: UBS reduces target price from 325p to 300p, while its buy recommendation is kept.HSBC Holdings: Investec reduces target price from 745p to 640p and downgrades from buy to hold.Hyder Consulting: Investec upgrades from hold to buy with a target price of 510p.Ithaca Energy: Canaccord Genuity lowers target price from 180p to 175p, while its buy recommendation is kept.Lonmin: RBC Capital cuts target price from 370p to 360p and retains an outperform rating.Marston's: JP Morgan reduces target price from 180p to 155p staying with its neutral rating.McBride: Investec places both its target price (prev.: 120p) and its buy recommendation under review. Panmure Gordon cuts target price from 120p to 100p downgrading from buy to hold.Merlin Entertainment: Deutsche Bank raises target price from 395p to 430p and stays with its buy recommendation.Minoan Group: WH Ireland shifts target price from 20p to 28p and stays with its speculative buy recommendation.Mitchells & Butlers: JP Morgan increases target price from 460p to 530p upgrading to overweight.Parkmead Group: Westhouse Securities initiates with a target price of 400p and a buy recommendation.Pennon Group: UBS takes target price from 725p to 795p and reiterates a buy recommendation.Polymetal International: Citi lowers target price from 452p to 450p and stays with its sell recommendation.Resolution: Canaccord Genuity reduces target price from 375p to 300p maintaining a hold recommendation.Restaurant Group: JP Morgan shifts target price from 750p to 755p retaining an overweight rating.Rotork: RBC Capital initiates with a target price of 2800p and a neutral rating.Severn Trent: UBS takes target price from 1825p to 1885p leaving its neutral rating unaltered.Smith & Nephew: Numis downgrades from add to hold with a target price of 1000p.Spirax-Sarco Engineering: RBC Capital initiates with a target price of 3250p and an outperform rating.Tullow Oil: UBS cuts target price from 925p to 900p, while upgrading from neutral to buy.United Utilities: UBS ups target price from 750p to 775p keeping a neutral rating.Wincanton: Investec upgrades from hold to buy with a target price of 155p.
More News
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.